In our analysis, we entered the data of a potential patient, with the following features (displayed in Figure 3): M-state: M1; T-state T4b; N-state: N2; ECOG: 1; recurrence: positive; progression during or after platinum-based therapy: negative; PD-L1 expression of tumor cells: TPS > 50%; and combined positive score for PD-L1 expression between 1 and 20: CPS > 1. The gene discussed is CD274; the disease is neoplasm.